Clinical trials
Biopsy clinical trials
Below are recruiting biopsy clinical trials, each written for real people, not researchers. We’re tracking 962 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07121998Recruiting
Study of resistance to alkylating chemotherapy in endocrine tumors
This study looks at why some endocrine tumors (tumors in hormone-making glands) stop responding to a specific type of chemotherapy called alkylating agents. Researchers will collect tissue samples to understand how the tumor changes and why the medicine stops working.
UppsalaAges 18 years+ - NCT07131566Recruiting
Immune response in neck lymph nodes in head and neck cancer
This study looks at how the immune system in the lymph nodes of the neck responds to head and neck cancer. It will help researchers understand how the body fights these cancers, which could lead to better treatments.
Stockholm, Stockholm CountyAges 18 years+ - NCT07138963Recruiting
Gene study in children with congenital muscle weakness
This study looks at how genes affect symptoms in children with congenital myopathies or congenital muscular dystrophies. It may help doctors better understand these conditions.
CairoAges 1–18 - NCT07140679RecruitingPhase 2
Immunotherapy after surgery for certain colon cancers
This trial tests whether the immunotherapy drug toripalimab can lower the risk of colon cancer coming back after surgery. It is for people with a specific genetic feature called mismatch repair deficiency (dMMR) in their tumor, and whose cancer was at a higher stage (stage IIB, IIC, or III).
Atlanta, GeorgiaAges 18 years+ - NCT07145177RecruitingPhase 1
Lu177-PSMA with liver treatment for advanced prostate cancer
This trial tests a targeted radiation drug (Lu177-PSMA) combined with procedures that treat liver tumors directly (like ablation or radiation). It is for men with prostate cancer that has spread to the liver and is no longer responding to hormone therapy. The goal is to see if this combination works better together.
San Francisco, CaliforniaAges 18 years+ - NCT07154563Recruiting
Quick test for breast cancer spread to lymph nodes using a new probe
This trial uses a special probe that lights up cancer cells to quickly check if breast cancer has spread to nearby lymph nodes. It may help doctors decide how much surgery is needed.
Kunming, YunnanAges 18–75 - NCT07155317RecruitingPhase 2
Time-of-day immunotherapy for advanced melanoma
This trial tests whether giving immunotherapy at a specific time of day can improve its effectiveness for advanced melanoma that cannot be removed by surgery. It may help you if you have stage IV melanoma and have not had immunotherapy in the last year.
Atlanta, GeorgiaAges 18 years+ - NCT07155954Recruiting
Super-Resolution Ultrasound to Tell Benign from Malignant Lymph Nodes
This study uses a special high-detail ultrasound technique to better tell if lymph nodes are harmless (benign) or cancerous (malignant). It may help avoid unnecessary biopsies or surgeries in the future.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07164027RecruitingEarly Phase 1
Comparing a new PSMA scan to MRI for prostate cancer detection
This trial tests whether a new imaging agent (flotufolastat F 18 PET CT) can find prostate cancer better than MRI. If you have a suspicious spot on an MRI, this study may help doctors see if the new scan is more accurate.
Los Angeles, CaliforniaAges 18–90 - NCT07168863Recruiting
Pancreas biopsy and pancreatitis risk study
This study looks at how often inflammation of the pancreas (pancreatitis) happens after a pancreas biopsy using a special scope (EUS) and needle (FNB). If you are getting a biopsy of a mass or cyst in your pancreas or nearby bile duct, this study will help doctors understand the risks better.
Tehran, Tehran ProvinceAges 18 years+ - NCT07168876Recruiting
A blood test to screen for colon cancer
This trial studies a new blood test that looks for specific markers of colon cancer. If it works well, it could offer an easier way to screen for the disease without a colonoscopy.
Mendoza, Mendoza ProvinceAges 45–75 - NCT07174570RecruitingPhase 2
Celecoxib with immunotherapy for advanced liver cancer
This trial tests a combination of two immunotherapy drugs (durvalumab and tremelimumab) plus a pain reliever (celecoxib) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if this three-drug combination works better than standard treatments.
Atlanta, GeorgiaAges 18 years+ - NCT07180212Recruiting
Urine DNA Test to Guide Cystoscopy in High-Risk Bladder Cancer
This trial tests a urine test that looks for tumor DNA to help doctors decide when you need a cystoscopy (a scope in the bladder). It is for people with high-risk or very high-risk non-muscle-invasive bladder cancer who have already had surgery to remove all visible tumors.
Xingtai, HebeiAges 18 years+ - NCT07180381Recruiting
A closer look at prostate MRI to avoid unnecessary biopsies
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
Emmen, DrentheAges 18 years+ - NCT07181941RecruitingPhase 1/Phase 2
Testing lower doses of linvoseltamab for multiple myeloma
This trial tests if a lower dose of linvoseltamab can still work well for people with multiple myeloma that has come back or not responded to treatment. It aims to reduce side effects while keeping the cancer under control.
Seattle, WashingtonAges 18 years+ - NCT07182214Recruiting
Lung cancer detection using a blood test for early signs
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
HsinchuAges 18 years+ - NCT07185165RecruitingPhase 2
PET Scan for Prostate Cancer Recurrence After Focal Therapy
This study uses a special PET/CT scan (Flotufolastat F 18) to look for leftover or returning prostate cancer after you've had a targeted treatment called focal therapy. The goal is to see if the scan can help find cancer that might need further treatment.
Los Angeles, CaliforniaAges 18–90 - NCT07187635Recruiting
Urine DNA test before a second bladder tumor surgery
This trial studies if a urine test for tumor DNA can help decide when a second surgery is needed for early stage bladder cancer. It may reduce unnecessary procedures for some patients.
Nanchang, AnhuiAges 18 years+ - NCT07203534Recruiting
Virtual reality for pain and anxiety during bone marrow biopsy
This study tests if using a virtual reality headset during and after a bone marrow biopsy can help reduce pain and anxiety. If you are scheduled for this procedure, you may be able to participate.
Charlotte, North CarolinaAges 18 years+ - NCT07214298RecruitingPhase 1/Phase 2
Combination study of pegcetacoplan and FOLFIRINOX for metastatic pancreatic cancer
This trial tests a new drug called pegcetacoplan combined with a standard chemotherapy regimen (FOLFIRINOX) for people with pancreatic cancer that has spread. The goal is to see if adding pegcetacoplan makes the treatment more effective.
Buffalo, New YorkAges 18 years+ - NCT07217054Recruiting
Parkinson's and RBD diagnosis via colon biopsy
This trial uses a small piece of colon tissue, taken during a routine colonoscopy, to look for a protein linked to Parkinson's disease and REM sleep behavior disorder (RBD). It aims to improve diagnosis for these conditions.
Branford, ConnecticutAges 40–99 - NCT07218510RecruitingPhase 2
Venetoclax, obinutuzumab, then epcoritamab for untreated CLL/SLL
This trial tests a new combination of three drugs for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have not had treatment yet. The goal is to see if this approach helps control the disease with fewer side effects.
Duarte, CaliforniaAges 18 years+ - NCT07219277Recruiting
Blood test to detect breast cancer early in women
This study tests a new blood test that aims to find breast cancer early in women who are at higher risk or are going for routine screening. If you are a woman aged 30–75 and are scheduled for a mammogram, MRI, or breast ultrasound, you may be able to help validate this test.
Phoenix, ArizonaAges 30–75 - NCT07224100RecruitingPhase 2
Chemo plus targeted drug for newly diagnosed Ph+ ALL
This trial tests a combination of chemotherapy drugs (EPOCH) plus a targeted therapy (ponatinib) for patients with a specific type of acute lymphoblastic leukemia (Ph+ ALL). Some participants also get rituximab if their leukemia cells have a certain marker (CD20). The goal is to see how well this treatment works as a first therapy.
Seattle, WashingtonAges 18 years+
Hear when a new Biopsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for biopsy?
- Yes. Clin2 currently lists 962 recruiting biopsy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biopsy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biopsy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.